Pharmazz, Inc.
Clinical trials sponsored by Pharmazz, Inc., explained in plain language.
-
New hope for a deadly lung condition that lacks effective drugs
Disease control Not yet recruitingThis study is testing if adding an investigational drug called centhaquine to standard hospital care can help patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of lung failure. About 80 hospitalized adults in intensive care will …
Phase: PHASE2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Breakthrough drug trial aims to rescue patients from fatal shock
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called centhaquine to standard emergency treatment can help save more lives from severe shock caused by major blood loss. Researchers will enroll 430 critically ill adults with dangerously low blood pressure to see if cent…
Phase: PHASE3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC